MILAN -- Women in their 70s and 80s diagnosed with metastatic breast cancer appear to benefit from treatment with trastuzumab (Herceptin), researchers reported at the European Society for Medical Oncology Conference.
Full Article
Monday, October 11, 2010
Older Women Too Can Benefit from Trastuzumab - in Meeting Coverage, ESMO from MedPage Today
MILAN -- Women in their 70s and 80s diagnosed with metastatic breast cancer appear to benefit from treatment with trastuzumab (Herceptin), researchers reported at the European Society for Medical Oncology Conference.
Full Article
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment